Search
Clinician Ordering Portal
Tests
Tests
Prognostic
DecisionDx-Melanoma
DecisionDx-SCC
TissueCypher
DecisionDx-UM
Diagnostic
MyPath Melanoma
Therapy Guidance
AdvanceAD-Tx
Patient Information
Patient Information
Dermatology
Cutaneous Melanoma
Cutaneous Squamous Cell Carcinoma
Atopic Dermatitis
Gastroenterology
Barrett's Esophagus
Ophthalmology
Uveal Melanoma
Science
Science
Technology
Gene Expression Profiling
Spatial Biology
Our Approach
Scientific Publications
Resources
Resources
Scientific Evidence
Provider Resources
Clinician Portal
Order a Test
Castle Connect
Patient Resources
Test Overviews
Patient Stories
Contact Us
Advocacy Groups & Forums
FAQ
Insurance Coverage
On Demand Education
Case Studies
Company
Company
Investors
Careers
Contact Us
Find a Representative
Leadership & Board of Directors
Castle Laboratories
Environmental, Social & Governance
News
Media Center
Investors
Contact
Order a Test
Search
Clinician Ordering Portal
Order Test
Contact
On-demand education
Filter
Test
Diagnostic
MyPath Melanoma
Prognostic
DecisionDx-Melanoma
DecisionDx-SCC
DecisionDx-UM
TissueCypher
AdvancedAD-Tx
Focus Area
Dermatology
Cutaneous Melanoma
Cutaneous Squamous Cell Carcinoma
Dermatology
Gastroenterology
Barrett's Esophagus
Ophthalmology
Uveal Melanoma
Format
Publication
Presentation
Poster
Whitepaper
Other
Evidence
Clinical Utility
Validation
Review Article
Guidelines
Patient Experience
Meta-analysis
Other
FILTER BY TESTS
DecisionDx-Melanoma
DecisionDx-SCC
TissueCypher
MyPath Melanoma
DecisionDx-UM
AdvancedAD-Tx
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004;64:7205-9.
October 15, 2004
DecisionDx-UM
Authors: Onken MD, Worley LA, Ehlers JP, et al.
View Video
View
Download PDF
Prognostic
Ophthalmology
1
7 / 7